Compare DUOT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOT | ANIK |
|---|---|---|
| Founded | 1990 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 198.9M |
| IPO Year | 2017 | 1996 |
| Metric | DUOT | ANIK |
|---|---|---|
| Price | $13.77 | $14.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $17.00 | $17.00 |
| AVG Volume (30 Days) | ★ 828.9K | 63.9K |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.96 | ★ 80.16 |
| EPS | ★ N/A | N/A |
| Revenue | $27,023,651.00 | ★ $112,819,000.00 |
| Revenue This Year | $50.98 | $5.98 |
| Revenue Next Year | N/A | $7.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 271.16 | N/A |
| 52 Week Low | $5.78 | $7.90 |
| 52 Week High | $15.28 | $16.24 |
| Indicator | DUOT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 68.08 | 44.10 |
| Support Level | $8.12 | $13.95 |
| Resistance Level | N/A | $15.98 |
| Average True Range (ATR) | 1.22 | 0.58 |
| MACD | 0.44 | -0.07 |
| Stochastic Oscillator | 80.36 | 25.63 |
Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.